Drug Treatment

Immunotherapy: Game Changing Cancer Treatments

Two recent articles summarize the promise that immunotherapy provides for the future of cancer treatment. Immunotherapy refers to treatments that aid your own immune system in fighting cancer cells. The first, from U.S. News [...]

By |2018-11-05T14:35:28-05:00October 15th, 2015|Drug Treatment, News, Research|

Need for Extended Adjuvant Treatment to Prevent Recurrence in GIST May Be Underestimated

A recent study in JAMA Oncology found that patients who undergo primary GIST resection might not receive the optimal recommended duration of adjuvant therapy, which can impact their recurrence-free survival (RFS). The study was [...]

Potential Treatment for Imatinib-Resistant GIST Explored

Dr. Ron DeMatteo GIST specialist surgeon Dr. Ron DeMatteo, along with colleagues at Memorial Sloan-Kettering Cancer Center (MSKCC), has published a new paper in the April issue of Cancer Research with potentially [...]

By |2019-10-31T12:01:35-04:00June 16th, 2015|Drug Treatment, News, Research|

Importance of Therapeutic Drug Monitoring for Targeted Therapies

As personalized medicine has become an accepted paradigm, it may be time for oncologists to examine personalized dose levels.In a recent article from Cancer World, the author explores the value of therapeutic drug monitoring for [...]

By |2019-04-08T10:18:30-04:00May 1st, 2015|Drug Treatment, News|

Study Indicates Use Of Adjuvant Imatinib Therapy For GIST Increasing

A recent study published in the American Journal of Clinical Oncology found that the use of adjuvant systemic therapy with imatinib for GIST has increased significantly over time, and that patients treated with the therapy [...]

By |2018-09-11T09:21:47-04:00April 7th, 2015|Drug Treatment, Gleevec, News, Survival Strategies|

Novartis Gains Approval for Panobinostat

Novartis Pharmaceuticals recently received FDA approval for panobinostat, a blood cancer drug that targets multiple myeloma. This was a surprising ruling, as it was a turnaround from last year’s Oncologic Drugs Advisory Committee’s 5-2 [...]

By |2019-04-08T09:34:28-04:00March 9th, 2015|Clinical Trials, Drug Treatment, News|
Go to Top